Added to YB: 2025-07-25
Pitch date: 2025-07-22
NOVO-B.CO [bullish]
Novo Nordisk A/S
-26.15%
current return
Author Info
No bio for this author
Company Info
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products.
Market Cap
DKK 1.3T
Pitch Price
DKK 405.49
Price Target
N/A
Dividend
3.91%
EV/EBITDA
8.10
P/E
11.43
EV/Sales
4.31
Sector
Pharmaceuticals
Category
growth
GUYQUITY 2025 Q2 Portfolio new position - Novo Nordisk A/S
NOVO-B.CO (new position): Ozempic/Wegovy leader dominating GLP-1 market for diabetes/obesity. Recent drop from high valuation, supply issues & US pricing fears, but long-term demand remains strong. Unlike typical biopharma, Novo has cash generation, ex-US pricing power, dividends & organic growth without M&A dependency.
Read full article (1 min)